The emerging treatment of the medication represents a exciting advance in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide661829.ambien-blog.com/48974031/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment